Two of the vaccines we have for COVID-19 have the distinction of being the first mRNA vaccines to see widespread use in ...

Scientists could soon develop personalized cancer vaccines.

Scientists are developing broad-spectrum vaccines that could protect against multiple virus families by targeting more ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. An experimental vaccine ...

Dozens of coronavirus vaccines entered clinical trials during 2020, and now, a handful have been authorized for emergency use in various countries — meaning the shots can be administered to the public ...

The FDA is reviewing the first mRNA flu vaccine for adults 50 and older. Learn how this technology could lead to faster and ...

Dr. Faisal Shuaib, Executive Director, National Primary Health Care Development Agency (NPHCDA) has given an insight into the composition of COVID-19 vaccines. He said while some had been approved for ...

Vaccines have prevented diseases that once caused paralysis, deafness, pneumonia, meningitis, liver failure, certain cancers and death. They are among the most significant medical breakthroughs in the ...

The adjuvanted respiratory syncytial virus (RSV) vaccine RSVPreF3 was immunogenic in lung transplant (LT) and allogeneic hematopoietic cell transplant (alloHCT) recipients. No vaccine-associated ...

Sievers is a vaccine researcher and Ph.D. candidate at the University of Cambridge and the NIH Vaccine Research Center. I’m a vaccine researcher. And I’m terrified of needles. It’s not something I’m ...

One of the lead authors of the study, Claire Gustafson, in the lab. Credit: Allen Institute Age-related shifts in T cells weaken vaccine response in older adults, but new findings pave the way for ...